United Therapeutics (UTHR) Tops Q4 EPS by 60c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $592.84 +0.91%
Revenue Growth %: -1.8%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
PHAR, EEFT, INIO, More
Revenue Growth %: -1.8%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
PHAR, EEFT, INIO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $7.70, $0.60 better than the analyst estimate of $7.10. Revenue for the quarter came in at $790.2 million versus the consensus estimate of $815.24 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo says positioning rotation over, time to pick stocks
- Public Service Enterprise Group Inc. (PEG) PT Lowered to $85 at BofA Securities
- JetBlue shares jump on Q3 results and 2027 outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
